Sterling Capital Management LLC Myriad Genetics Inc Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Sterling Capital Management LLC holds 308 shares of MYGN stock, worth $4,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
308Holding current value
$4,860% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MYGN
# of Institutions
254Shares Held
90.3MCall Options Held
100KPut Options Held
34K-
Black Rock Inc. New York, NY15.2MShares$239 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$163 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.72MShares$106 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$81.7 Million0.07% of portfolio
-
State Street Corp Boston, MA4.7MShares$74.2 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.27B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...